The Chicago-based 7th U.S. Circuit Court of Appeals recently reversed a class-action certification order in a consumer lawsuit that alleged that the eye drops used to treat glaucoma were larger than necessary, and those who used the drops were overpaying. Even if the defendants – Allergan, Alcon, Bausch and Lomb, Pfizer, Merck and Prasco – sold tiny eye drops that were cheaper and just as effective, consumers still got what they paid for, Judge Richard Posner wrote for court.
Category: Glaucoma
Industry Snapshot: Setting Sights On Glaucoma Drug Makers
Glaucoma refers to a collection of similar degenerative ocular diseases primarily caused by an increase in fluid pressure within the eye. Reuters pegged the global glaucoma market at $5.6 billion in 2015 and the market will likely keep growing as the population ages.
Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments
Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, today announced that the two companies have entered into a strategic research collaboration focused on the identification of new drug candidates for glaucoma. Under the agreement, twoXAR will use its proprietary computational drug discovery platform to discover, screen, and prioritize novel drug candidates with potential application in ocular indications, with a specific focus on glaucoma.
Aerie Pharmaceuticals Announces Appointment of Huan Sheng, M.D.,…
Aerie Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Huan Sheng, M.D., Ph.D., as Director Clinical Research and Drug Safety, reporting to Kristine Erickson, O.D., Ph.D., Aerie’s Vice President Clinical Research. Dr. Sheng will be responsible for the development and implementation of Aerie’s drug safety surveillance and clinical research strategy, and the management and oversight of Aerie’s clinical development and drug safety programs.
Salt Lake City Eye Surgeons Promote Glaucoma Awareness For High-Risk Individuals
… Month and making extra efforts during January to educate their patients about this serious disease. The National Eye Health Education Program (NEHEP) cites glaucoma as a leading cause of vision loss and blindness in the United States. The Glaucoma …
Fresh vision for glaucoma treatment
DON’T BLINL: Joseph Nazarian performs an eye test at Nazarian Optometrist, Wespoint, as part of a pilot program for diabetes and glaucoma. Picture: Isabella Lettini Eye patients in serious need of treatment are jumping the queue thanks to an innovative approach being trialled in Blacktown.
Global Glaucoma Epidemiology and Patient Flow Analysis – 2017 – Research and Markets
… estimate Glaucoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to ealuate market opportunities, effectively identify …
Here’s Why Inotek Pharmaceuticals Corp. Is Being Obliterated
Shares are collapsing in early-morning trading on Tuesday, falling more than 68% as of 10:05 a.m EST after the company reported results from a phase 3 study that failed to meet its primary endpoint. announced top-line results of its MATrX-1 trial on Tuesday.
Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System
Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB360 Trabeculotomy System. The TRAB360 is indicated in Canada for the microcatheterization of Schlemm’s canal and cutting of trabecular meshwork to lower intraocular pressure in patients with primary open angle glaucoma.
English
… f the highest-quality eye care. Our EyeSmartA program provides the public with the most trusted information about eye health. For more information, visit aao.org .
Fischer Laser Eye Center Opens New Office in Benson, Minnesota
The doctors of Fischer Laser Eye Center will begin seeing patients at their new office in Benson, Minnesota, starting January 2017. In January of 2017, the family eye doctors of Fischer Laser Eye Center will begin seeing patients at their new Benson, Minnesota, office located inside the recently constructed DoMats grocery store on 1705 Minnesota Avenue .